Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
Verlagsversion
Forschungsdaten
DOI
PMC
 |
Open Access Gold (Paid Option) |
|
möglich sobald bei der ZB eingereicht worden ist.
Multi-targeting macrocyclic peptides as nanomolar inhibitors of self- and cross-seeded amyloid self-assembly of α-synuclein.
Angew. Chem.-Int. Edit.:e202422834 (2025)
Verlagsversion
Forschungsdaten
DOI
PMC
Amyloid self-assembly of α-synuclein (αSyn) is linked to the pathogenesis of Parkinson's disease (PD). Type 2 diabetes (T2D) has recently emerged as a risk factor for PD. Cross-interactions between their amyloidogenic proteins may act as molecular links. In fact, fibrils of islet amyloid polypeptide (IAPP) (T2D) can cross-seed αSyn amyloidogenesis and αSyn and IAPP colocalize in PD brains. Inhibition of both self- and IAPP-cross-seeded αSyn amyloidogenesis could thus interfere with PD pathogenesis. Here we show that macrocyclic peptides, designed to mimic IAPP self-/cross-interaction sites and previously found to inhibit amyloidogenesis of IAPP and/or Alzheimer's disease (AD) amyloid-β peptide Aβ40(42), are nanomolar inhibitors of both self- and IAPP-cross-seeded amyloid self-assembly of αSyn. Anti-amyloid function is mediated by nanomolar affinity interactions with αSyn via three αSyn regions which are identified as key sites of both αSyn self-assembly and its cross-interactions with IAPP. We also show that the peptides block Aβ42-mediated cross-seeding of αSyn as well. Based on their broad spectrum anti-amyloid function and additional drug-like features, these peptides are leads for multifunctional anti-amyloid drugs in PD, T2D, AD, and their comorbidities, while the identified αSyn key segments are valuable targets for novel, multi-site targeting amyloid inhibitors in PD and related synucleinopathies.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
(cross-)seeding ; Protein-protein Interactions ; Self-assembly ; A-synuclein ; Amyloid Inhibitor; A-beta; Parkinsons-disease; Designed Peptides; Iapp; Aggregation; Protein; Toxicity; Polypeptide; Oligomers; Regions
ISSN (print) / ISBN
1433-7851
e-ISSN
1521-3773
Zeitschrift
Angewandte Chemie - Internationale Edition
Quellenangaben
Artikelnummer: e202422834
Verlag
Wiley
Verlagsort
Weinheim
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
CF Monoclonal Antibodies (CF-MAB)
Förderungen
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
DFG under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology
JPND Consortium, SynOD ,,alpha-Synuclein OMICS - Federal Ministry of Education and Research, BMBF
Studienstiftung des Deutschen Volkes e. V
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
DFG under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology
JPND Consortium, SynOD ,,alpha-Synuclein OMICS - Federal Ministry of Education and Research, BMBF
Studienstiftung des Deutschen Volkes e. V